NCT03822364 - Staccato Apomorphine Single and Multi Dose PK | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 26, 2018

Primary Completion Date

March 26, 2019

Study Completion Date

March 26, 2019

Conditions

Parkinson Disease

Interventions

DRUG

009-1

Inhaled apomorphine via Staccato aerosol, Dose 1

DRUG

active comparator

commercially available apomorphine injector

DRUG

009-0

Inhaled placebo via Staccato device

DRUG

009-2

Inhaled apomorphine via Staccato aerosol, Dose 2

DRUG

009-3

Inhaled apomorphine via Staccato aerosol, Dose 3

DRUG

009-4

Inhaled apomorphine via Staccato aerosol, Dose 4

DRUG

009-5

Inhaled apomorphine via Staccato aerosol, Dose 5

Trial Locations (1)

Center for Human Drug Research, Leiden